Meihua International Medical Technologies Co., Ltd. (MHUA) P/E Ratio History
Historical price-to-earnings valuation from 2022 to 2025
Loading P/E history...
MHUA Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Meihua International Medical Technologies Co., Ltd. (MHUA) trades at a price-to-earnings ratio of 0.2x, with a stock price of $7.61 and trailing twelve-month earnings per share of $58.15.
The current P/E is 92% below its 5-year average of 2.3x. Over the past five years, MHUA's P/E has ranged from a low of 0.4x to a high of 6.2x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, MHUA trades at a 99% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, MHUA trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MHUA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
MHUA P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $134M | 32.2 | 7.51 | +16% | |
| $4B | 29.3 | - | +5% | |
| $2B | 6.9Lowest | 0.67Best | +817%Best | |
| $100B | 21.6 | - | +31% | |
| $113B | 35.0 | 2.36 | +8% | |
| $84B | 29.2 | - | +55% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
MHUA Historical P/E Data (2022–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $40.00 | $65.28 | 0.6x | -73% |
| FY2024 Q4 | $34.51 | $85.42 | 0.4x | -82% | |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $85.19 | $63.12 | 1.3x | -41% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $148.00 | $76.76 | 1.9x | -15% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $285.00 | $117.70 | 2.4x | +7% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $828.00 | $133.70 | 6.2x | +173% |
| FY2022 Q2 | $530.00 | $177.00 | 3.0x | +32% |
Average P/E for displayed period: 2.3x
See MHUA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MHUA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MHUA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMHUA — Frequently Asked Questions
Quick answers to the most common questions about buying MHUA stock.
Is MHUA stock overvalued or undervalued?
MHUA trades at 0.2x P/E, below its 5-year average of 2.3x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does MHUA's valuation compare to peers?
Meihua International Medical Technologies Co., Ltd. P/E of 0.2x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is MHUA's PEG ratio?
MHUA PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2025.